Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Wyeth |
---|---|
Information provided by: | Wyeth |
ClinicalTrials.gov Identifier: | NCT00434187 |
The primary objective is evaluate the safety, tolerability, and pharmacokinetics of multiple doses of ERB-041, an investigational drug, in healthy, female Japanese subjects.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Drug: ERB-041 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety Study |
Official Title: | An Ascending Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics of ERB-041 Administered Orally to Healthy, Female Japanese Subjects |
Ages Eligible for Study: | 20 Years to 45 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Study ID Numbers: | 3142A2-115 |
Study First Received: | February 9, 2007 |
Last Updated: | February 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00434187 History of Changes |
Health Authority: | Japan: Pharmaceuticals and Medical Devices Agency |
healthy |
Healthy |